HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma

BACKGROUND: Although clear cell renal cell carcinoma (ccRCC) is well known as a highly immunogenic tumor, only a small subset of patients could benefit from current immunotherapy, which might be due to the heterogeneity of immune microenvironment in ccRCC. So, it is meaningful to explore novel immun...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Immunother Cancer
Main Authors: Zhou, Qiang-Hua, Li, Kai-Wen, Chen, Xu, He, Hai-Xia, Peng, Sheng-Meng, Peng, Shi-Rong, Wang, Qiong, Li, Ze-An, Tao, Yi-Ran, Cai, Wen-Li, Liu, Ran-Yi, Huang, Hai
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2020
Fag:
Immunotherapy Biomarkers
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057441/
https://ncbi.nlm.nih.gov/pubmed/31959726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000157
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker